Skip to main content

Main navigation

    • About us
    • Our work
    • Rationale
    • IDDO Team
    • Contact us
    • Our partners
    • Governance
    • IDDO Board
    • Data Access Committee
    • Data reuse
    • Contributing data
    • Accessing data
    • IDDO legal and regulatory documentation
    • IDDO data sharing registrations
    • Data Access Guidelines
    • Frequently Asked Questions
    • Research themes
    • WWARN - malaria
    • COVID-19
    • Ebola
    • Visceral leishmaniasis
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
    • Research
    • Malaria Tracking Resistance
    • Malaria Clinical Trials Toolkit
    • COVID-19 LSR Tool
    • VL Tool
    • Medicine Quality Monitoring Globe
    • Medicine Quality Scientific Literature Surveyor
    • Febrile Illness Surveyor
    • Publications
    • Tools & resources
    • Medical Product Quality Reports
  • News

User account menu

  • Log in
  • Register
  • Contact
Bande passanteélevée

Language switcher

  • English
  • Français
  • Español
    • About us
    • Overview
    • Our partners
    • Team
    • Governance
    • COVID-19 Data Access Committee
    • Accessing data
    • Contributing data
    • Benefits of data reuse
    • Approved uses of platform data
    • COVID-19 Mapping Review
    • Medicine Quality monitoring
    • Publications
    • Tools and resources
  • News
Please note that the content has been automatically translated from English original. There may on occasion be slight inaccuracies in this automatic translation

News

Medics in PPE on COVID-19 ward
i
Credit: DNDi, Tygerberg Testing-COVID19
News Article
20 Jul 2022
Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis
IDDO infographic
News Article
23 May 2022
IDDO’s latest newsletter is out
Geneva Health Forum logo
News Article
27 Apr 2022
IDDO at the Geneva Health Forum 4 May 2022
ANTICOV logo
News Article
28 Feb 2022
ANTICOV trial finds drug combination nitazoxanide + ciclesonide does not reduce risk of hospitalization in COVID-19 outpatients
School girls
i
Credit Jessica Lea, DFID
News Article
10 Feb 2022
Applications open for RSTMH 2022 grant programme
ANTICOV logo
News Article
10 Feb 2022
ANTICOV: clinical trial for COVID-19 in low-resource settings to test a new combination treatment, fluoxetine and budesonide
covid19
i
Credit NIH
News Article
18 Oct 2021
IDDO to make its COVID-19 studies discoverable on the Vivli platform
Global map
i
istock
News Article
02 Sep 2021
IDDO to share latest research at ECTMIH 2021
Blurred people on a busy street
i
CREDIT: Mauro Mora
News Article
29 Jul 2021
Preprints: it’s time to agree on terminology and best practice
ANTICOV logo
News Article
27 Apr 2021
ANTICOV: largest clinical trial in Africa for people with mild COVID-19 to test new drug combination
Professor Philippe Guérin
News Article
29 Mar 2021
Calls for clarity on pooled evidence in COVID-19 therapeutic reviews and guidelines
Gloved hand holding syringe inserted into small vial
i
Credit: Stockphotokun
News Article
16 Mar 2021
New report highlights growing concern of vaccine falsification

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Next page ››
  • Last page Last »

Sign up for the IDDO newsletter

Sign up for the WWARN newsletter
linkedin [#161] Created with Sketch. youtube

Footer menu

  • Cookies
  • Privacy Notice
  • Accessibility
  • Sitemap
  • Terms of use
© 2025 Infectious Diseases Data Observatory